Tinzaparin
Tinzaparin
Tinzaparin (pronounced tin-ZAP-uh-rin) is a type of anticoagulant medication that is used to prevent and treat blood clots. It belongs to a class of drugs known as low molecular weight heparin (LMWH).
Etymology
The name "Tinzaparin" is derived from its chemical structure. The prefix "Tinza-" is a modification of the word "Heparin", which is a naturally occurring anticoagulant found in the body. The suffix "-parin" is a common ending for anticoagulant drugs.
Usage
Tinzaparin is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in the treatment of unstable angina and non-Q wave myocardial infarction. Tinzaparin works by blocking the activity of certain clotting factors in the blood, thereby preventing the formation of blood clots.
Administration
Tinzaparin is administered by subcutaneous injection. The dosage and duration of treatment are determined by the patient's weight, the condition being treated, and the patient's response to therapy.
Side Effects
Common side effects of Tinzaparin include bleeding, bruising at the injection site, and mild irritation. Serious side effects can include severe bleeding, allergic reactions, and thrombocytopenia (low platelet count).
Related Terms
- Anticoagulant
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Unstable Angina
- Non-Q Wave Myocardial Infarction
- Thrombocytopenia
External links
- Medical encyclopedia article on Tinzaparin
- Wikipedia's article - Tinzaparin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski